Category Archives: People

PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients

Partnership combines trusted patient communities with flexible trial participation options to help sponsors enroll faster and retain patients. BOSTON and MORRISVILLE, N.C., July 21, 2026 (GLOBE NEWSWIRE) — PatientsLikeMe (“PLM”) Powered by Fuze Health, a leading patient engagement and health insights platform, and Science 37, the industry-leading patient access company for clinical research, today announced […]

Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries

Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary Fibrosis Company on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) — Rein Therapeutics, Inc. (“Rein” or the “Company”) (NASDAQ: RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for […]

European Patent Office Confirms Patent Protection for SOT201, SOTIO’s Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity

PRAGUE and BASEL, Switzerland and BOSTON, July 21, 2026 (GLOBE NEWSWIRE) — SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced that the Boards of Appeal of the European Patent Office (EPO) have upheld European Patent EP 3 444 271 B1, reinforcing intellectual property protection for SOT201, the company’s next-generation PD-1-targeting immunocytokine […]

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patient in Q1 2027   Company demonstrated the versatility of the RedTail platform with new CLD-501 data demonstrating the simultaneous in situ delivery of a TROP-2-targeted tumor-localized T-cell engager (TCE) alongside a T-cell amplifiers. The Company is also advancing its EpCam-targeted In Situ TCE program. In […]

My Derma Dream Expands Beauty Technology Portfolio With Launch of Myoglow Multi-modal Skin Sculpting Device

Miami, United States, July 20, 2026 (GLOBE NEWSWIRE) — My Derma Dream Expands Beauty Technology Portfolio With Launch of Myoglow Multi-modal Skin Sculpting Device Miami, United States, July 20th, 2026, Financewire My Derma Dream, a developer of non-invasive beauty technology, today announced the release of MyoGlow, a handheld multi-modal skin-tightening device designed for at-home dermal […]

Puerto Rico’s Day at The Ballpark Continues 2026 Series with Texas Rangers

ARLINGTON, TEXAS, July 20, 2026 (GLOBE NEWSWIRE) — — Discover Puerto Rico celebrates Puerto Rico’s baseball legacy in Arlington — Puerto Rico’s Day at the Ballpark continues its 2026 nationwide series on July 21 at Globe Life Field as the Chicago White Sox visit the Texas Rangers. Presented by Discover Puerto Rico and produced by […]

Bleached and Unbleached Tea Bags: Safety, Flavour, Chlorine and Key Differences Explained

Tea experts answer: Are bleached tea bags safe? Do they contain chlorine? Can unbleached tea bags affect flavour? And what’s the difference between the two? London, July 20, 2026 (GLOBE NEWSWIRE) — Consumers are increasingly asking whether unbleached tea bags are safer, healthier or more natural than bleached alternatives. According to Poonam Dharman – Packaging […]

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

Presentations to cover updates across Eikon’s clinical pipeline including:  Updated data from TeLuRide-005, an ongoing Phase 2 trial of EIK1001, a TLR7/8 dual agonist, plus pembrolizumab and chemotherapy in stage 4 non-small cell lung cancer (NSCLC) Updated cohort data from an ongoing Phase 1/2 study of EIK1003, a highly selective non-brain penetrant PARP1 inhibitor, as […]

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026

Management to host conference call on Thursday, July 30, 2026, at 8:00 am EDT FLORHAM PARK, N.J., July 20, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced that it will host a live webcast at 8:00 am EDT […]

Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion

  ● As of July 18, 2026, net asset value (NAV1) per share was $66.16         ● As of July 18, 2026, Enlivex held 79,550,593,122 RAIN tokens with a total value of approximately $1.1 billion2. Nes-Ziona, Israel, July 20, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a […]